Last Updated on December 30, 2023 by The Health Master
The Indian Pharmacopoeia Commission (IPC) will be organizing a webinar on “Key role of medical technology / medical device industries in Materiovigilance Programme of India’ (MvPI) in association of Central Drugs Standard Control Organisation (CDSCO) and Association of Indian Medical Device Industry (AiMeD) on December 10, 2021.
The speakers include:
- Dr V G Somani, Drugs Controller General of India (DCGI) , CDSCO,
- Rajiv Nath, forum coordinator, AiMeD,
- Dr Jitendra Sharma, CEO, Andhra Pradesh Med Tech Zone,
- Rajeev Singh Raghuvanshi, secretary-cum-scientific Director, IPC
- Dr. Vivekanandan Kalaiselvan, Senior Principal Scientific Officer, IPC.
This webinar will sensitize the manufacturers, importers, distributors of medical devices, including all healthcare stakeholders across India in order to promoting the patient safety and strengthening of materiovigilance system in India.
The manufacturers, distributors, importers, regulators of medical devices, healthcare professionals and researchers can attend this webinar.
The expected outcome of this webinar is to stimulate the culture of adverse event reporting associated with medical devices and the strengthening of an effective materiovigilance system across the country.
The registration fees is Rs.1,000 (including 18% GST) per participant.
AiMeD is an umbrella association of Indian Manufacturers of Medical Devices covering all types of medical devices, including consumables, disposables, equipments, instruments, electronics, diagnostics and implants.
Materiovigilance Programme of India has the responsibility to monitor, collate, and analyse the adverse events associated with the use of medical devices in the Indian population.
The vision of IPC is to promote the highest standards of drugs for use in human and animals within practical limits of the technologies available for manufacture and analysis.
IPC is an autonomous institution of the ministry of health and family welfare, Government of India.
IPC is created to set standards of drugs in the country. Its basic function is to update regularly the standards of drugs commonly required for treatment of diseases prevailing in this region.
The mandate of the commission is to perform, inter-alia, functions such as revision and publication of the Indian Pharmacopoeia and National Formulary of India on a regular basis besides providing IP reference substances and training to the stakeholders on pharmacopoeial issues.
Latest Circulars: (IPC) Indian Pharmacopoeia Commission
Latest Notifications regarding Pharmaceuticals
Latest on National Formulary of India (NFI)
Licensing procedure for Medical devices
Latest Notifications: Medical Devices
Classifications of Medical Devices under the provisions of MDR 2017
FAQs on Medical Devices Rules, 2017
FAQs – on Blood Pressure Monitoring Devices
USFDA promises quick review of Pfizer booster vaccine for all adults
Cipla launches portable Spirometer for early diagnosis for COPD
MSN Labs launches Vigabatrin Powder for the treatment of Epilepsy
Aleor Derma gets USFDA nod for Antibacterial Cream: Alembic
No retention or renewal fees after one time registration of ASU products
International Conference on National Education Policy will be held at …
IPC adds new impurities and Reference Standards: Download the list
Drug alert: 36 out of 1061 samples declared as NSQ in October 2021
Latest Circulars by the Govt of India, Dept of Pharmaceuticals, Health…
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
